Yes, I agree. There's a lot of very exciting stuff in the pipeline. Most of it won't end up panning out (see @kujhawk1978 's excellent summary of research stages a few posts earlier), but that's OK. We don't need them all to succeed; even if most fail, one or two successes could be enough to tip the balance for us.

(I wish I did know which 2 or 3 of the dozens of "promising" PCa treatments in early research will make it, because then I could take all of our family's savings and invest them in the company that's doing them. Even if I didn't live long enough to make millions, it would be a nice nest egg for my family. 😉 ).